JY
COLL icon

Jeff Yass’s Collegium Pharmaceutical COLL Stock Holding History

Jeff Yass’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
+37,400
New +$1.28M ﹤0.01% 7421
2022
Q3 		– Sell
-11,100
Closed -$197K – 13274
2022
Q2 		$197K Hold
11,100
– – ﹤0.01% 10649
2022
Q1 		$226K Buy
+11,100
New +$210K ﹤0.01% 10947
2021
Q2 		– Sell
-35,000
Closed -$830K – 12617
2021
Q1 		$830K Sell
35,000
-24,200
-41% -$575K ﹤0.01% 8213
2020
Q4 		$1.19M Buy
59,200
+33,400
+129% +$652K ﹤0.01% 6317
2020
Q3 		$537K Sell
25,800
-1,000
-4% -$18.1K ﹤0.01% 7512
2020
Q2 		$469K Sell
26,800
-35,200
-57% -$689K ﹤0.01% 7492
2020
Q1 		$1.01M Buy
62,000
+50,500
+439% +$1.04M ﹤0.01% 5372
2019
Q4 		$237K Sell
11,500
-10,100
-47% -$168K ﹤0.01% 8453
2019
Q3 		$248K Sell
21,600
-10,400
-33% -$119K ﹤0.01% 8689
2019
Q2 		$421K Buy
32,000
+19,000
+146% +$254K ﹤0.01% 7628
2019
Q1 		$197K Sell
13,000
-5,600
-30% -$89.7K ﹤0.01% 7891
2018
Q4 		$319K Sell
18,600
-22,800
-55% -$390K ﹤0.01% 6880
2018
Q3 		$610K Buy
41,400
+1,000
+2% +$17.7K ﹤0.01% 6167
2018
Q2 		$964K Buy
40,400
+17,900
+80% +$440K ﹤0.01% 5428
2018
Q1 		$575K Sell
22,500
-16,600
-42% -$396K ﹤0.01% 6352
2017
Q4 		$722K Buy
39,100
+15,800
+68% +$226K ﹤0.01% 5884
2017
Q3 		$244K Buy
23,300
+10,100
+77% +$111K ﹤0.01% 7719
2017
Q2 		$165K Buy
+13,200
New +$130K ﹤0.01% 8438

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Jeff Yass's COLL Position: Q2 2026 in Review

Jeff Yass reduced its Collegium Pharmaceutical (COLL) stake by 32% in Q2 2026, selling an estimated $272K and leaving 17,199 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #9391.

Jeff Yass first reported a position in COLL in Q3 2015 and has held it in 26 quarters since. The position peaked at $1.87M in Q2 2018. 277 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Jeff Yass held 17,199 shares of Collegium Pharmaceutical worth $623K as of Q2 2026.
  • Jeff Yass sold 7,958 Collegium Pharmaceutical shares in Q2 2026, an estimated $272K.
  • Collegium Pharmaceutical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9391 holding.
  • Jeff Yass first reported a position in Collegium Pharmaceutical in Q3 2015 and has held it in 26 quarters since.
  • Jeff Yass's Collegium Pharmaceutical position peaked at $1.87M in Q2 2018.
  • 277 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.